Highlights
- Cipla shares traded higher during Friday's morning session on the National Stock Exchange.
- The pharmaceutical company reported consolidated Q4 FY26 net profit of Rs 542.51 crore.
- The stock remained below its 52-week high while recording positive short-term returns.
Cipla Ltd. (NSE:CIPLA) traded higher during the morning session on July 3, 2026, with the stock rising 0.49% to Rs 1,463.20 at 11:29 AM IST. The stock opened at Rs 1,452.00 against the previous closing price of Rs 1,456.00. During the session, it touched an intraday high of Rs 1,471.00 and a low of Rs 1,452.00. The volume-weighted average price (VWAP) stood at Rs 1,461.81, reflecting steady trading during the session.
Trading Activity Remains Steady
Cipla witnessed active trading on the National Stock Exchange, with approximately 4.52 lakh shares changing hands by 11:29 AM IST. The traded value stood at around Rs 66.02 crore. The order book reflected marginally higher selling interest than buying interest, with sell-side orders accounting for 52.56% of the visible quantity compared with 47.44% on the buy side. The impact cost remained at 0.02, indicating adequate liquidity in the counter.
Stock Trades Below 52-Week High
The stock continued to trade below its 52-week high of Rs 1,673.00 recorded on October 23, 2025. However, it remained comfortably above its 52-week low of Rs 1,165.70 touched on April 2, 2026. At the prevailing market price, Cipla's market capitalisation stood at approximately Rs 1.18 lakh crore, while its free-float market capitalisation was around Rs 82,101.61 crore.
Share Performance Across Different Time Frames
Cipla has delivered mixed returns across different investment periods. The stock has gained 1.60% over the past week and 6.40% during the last month. On a year-to-date basis, it has declined 2.51%, while the one-year return stands at negative 3.02%. Over the past three years, the stock has generated an absolute return of 46.06%, while its five-year return stands at 49.43%. Cipla is a constituent of the Nifty 50 index and operates in the pharmaceuticals industry.
Q4 FY26 Financial Performance
For the quarter ended March 31, 2026, Cipla reported consolidated total income of Rs 6,68,936 lakh. Consolidated profit before tax stood at Rs 70,706 lakh, while consolidated net profit came in at Rs 54,251 lakh. Earnings per share (EPS) for the quarter were reported at Rs 6.87.
On a standalone basis, the company reported total income of Rs 4,39,020 lakh. Profit before tax stood at Rs 52,248 lakh, while net profit was Rs 38,464 lakh. Standalone earnings per share came in at Rs 4.76. The financial results were announced on May 13, 2026.
Valuation and Market Metrics
Cipla traded at a price-to-earnings (P/E) ratio of 30.40, while its adjusted P/E stood at 28.72. The stock recorded daily volatility of 1.43% and annualised volatility of 27.32%. Deliverable trades accounted for 52.63% of the total traded quantity during the session, indicating that more than half of the traded shares resulted in delivery-based transactions.
Key Risks
- Regulatory approvals may affect product launches.
- Pricing pressure could influence pharmaceutical margins.
- Currency fluctuations may impact export earnings.
- Market volatility can affect healthcare sector valuations.
Summary
Cipla shares traded modestly higher during the morning session on July 3, 2026, gaining 0.49% on the National Stock Exchange. The stock remained below its 52-week high while recording positive returns over the past week and month. The company's latest quarterly results reported consolidated net profit of Rs 542.51 crore and earnings per share of Rs 6.87.
FAQs
Q: What was Cipla's share price on July 3, 2026?
A: Cipla traded at Rs 1,463.20 at 11:29 AM IST, up 0.49% from the previous closing price.
Q: What was Cipla's consolidated net profit in Q4 FY26?
A: Cipla reported consolidated net profit of Rs 542.51 crore for the quarter ended March 31, 2026.
Q: What are Cipla's 52-week high and low share prices?
A: Cipla's 52-week high is Rs 1,673.00, while its 52-week low is Rs 1,165.70.